Nodular lymphocyte predominant hodgkin lymphoma: Biology, diagnosis and treatment

Clinical Lymphoma, Myeloma and Leukemia

Volumn 14, Issue 4, 2014, Pages 261-270

  Goel, Anupama ^a,b   Fan, Wen ^a,b   Patel, Amit A ^a   Devabhaktuni, Madhuri ^a   Grossbard, Michael L ^a,b  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^b MOUNT SINAI HEALTH SYSTEM   (United States)

Author keywords

Hodgkin lymphoma; LP cell; NLPHL; Popcorn cell; Reed Sternberg cells

Indexed keywords

BLEOMYCIN; CARMUSTINE; CD15 ANTIGEN; CD19 ANTIGEN; CD20 ANTIGEN; CD30 ANTIGEN; CD45 ANTIGEN; CD79A ANTIGEN; CHLORMETHINE; CYCLOPHOSPHAMIDE; CYTARABINE; DACARBAZINE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; MELPHALAN; METHOTREXATE; METHYLPREDNISOLONE; MITOXANTRONE; ORGANIC CATION TRANSPORTER 2; PREDNISONE; PROCARBAZINE; PROTEIN; PROTEIN BOB1; RITUXIMAB; UNCLASSIFIED DRUG; VINBLASTINE; VINCRISTINE;

AUTOLOGOUS STEM CELL TRANSPLANTATION; B LYMPHOCYTE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER STAGING; CANCER SURGERY; CLINICAL FEATURE; FAILURE FREE SURVIVAL; HISTIOCYTE; HISTOPATHOLOGY; HUMAN; IMMUNOPHENOTYPING; LARGE CELL LYMPHOMA; LYMPHOCYTE; MOLECULAR BIOLOGY; MULTIPLE CYCLE TREATMENT; NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA; PHENOTYPE; PROGRESSION FREE SURVIVAL; RECURRENCE FREE SURVIVAL; REVIEW; TREATMENT OUTCOME; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; DISEASE COURSE; HODGKIN DISEASE; METABOLISM; NEOPLASMS, SECOND PRIMARY; PATHOLOGY; RECURRENT DISEASE;

B-LYMPHOCYTES; DISEASE PROGRESSION; HODGKIN DISEASE; HUMANS; NEOPLASM STAGING; NEOPLASMS, SECOND PRIMARY; PHENOTYPE; RECURRENCE;

EID: 84904647397     PISSN: 21522650     EISSN: 21522669     Source Type: Journal    
DOI: 10.1016/j.clml.2014.01.006     Document Type: Review

References (41)

1. S.H. Swerdlow, E. Campo, and N.L. Harris et al. World Health Organization Classification of Tumors of Haematopoietic and Lymphoid Tissues 2008 IARC Press Lyon, France
2. V. Diehl, M. Sextro, and J. Franklin et al. Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: report from the European Task Force on Lymphoma project on lymphocyte-predominant Hodgkin's disease J Clin Oncol 17 1999 776 783
3. I. Anagnostopoulos, M.L. Hansmann, and K. Franssila et al. European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes http://www.ncbi.nlm.nih.gov/pubmed/10961891 Blood 96 2000 1889 1899
4. L.M. Morton, S.S. Wang, and S.S. Devesa et al. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001 Blood 107 2006 265 276
5. R.K. Thomas, D. Re, J. Wolf, and V. Diehl Part 1: Hodgkin's lymphoma - molecular biology of Hodgkin and Reed-Sternberg cells Lancet Oncol 5 2004 11 18
6. DeVita VT, Jr, Lawrence TS, Rosenberg SA, DePinho RA, Weinberg RA. Devita, Hellman, and Rosenberg's Cancer: Principles and Practice of Oncology. 9th ed. New York, NY: Lippincot Williams & Wilkins; 2011.
7. B.F. Burns, T.V. Colby, and R.F. Dorfman Differential diagnostic features of nodular L & H Hodgkin's disease, including progressive transformation of germinal centers Am J Surg Pathol 8 1984 253 261
8. L. Boudova, E. Torlakovic, and J. Delabie et al. Nodular lymphocyte-predominant Hodgkin's lymphoma with nodules resembling T-cell/histiocyte-rich B-cell lymphoma: differential diagnosis between nodular lymphocyte predominant hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma Blood 102 2003 3753 3758
9. J. Hicks, and C. Flaitz Progressive transformation of germinal centers: review of histopathologic and clinical features Int J Pediatr Otorhinolaryngol 65 2002 195 202
10. A. Braeuninger, R. Küppers, J.G. Strickler, H.H. Wacker, K. Rajewsky, and M.L. Hansmann Hodgkin and Reed-Sternberg cells in lymphocyte predominant Hodgkin disease represent clonal populations of germinal center-derived tumor B cells Proc Natl Acad Sci U S A 94 1997 9337 9342
11. T. Marafioti, M. Hummel, and I. Anagnostopoulos et al. Origin of nodular lymphocyte-predominant Hodgkin's disease from a clonal expansion of highly mutated germinal-center B cells N Engl J Med 337 1997 453 458
12. T. Ohno, J.A. Stribley, G. Wu, S.H. Hinrichs, D.D. Weisenburger, and W.C. Chan Clonality in nodular lymphocyte-predominant Hodgkin's disease N Engl J Med 337 1997 459 465
13. A. Liso, D. Capello, and T. Marafioti et al. Aberrant somatic hypermutation in tumor cells of nodular-lymphocyte-predominant and classic Hodgkin lymphoma Blood 108 2006 1013 1020
14. T. Marafioti, M. Pozzobon, M.L. Hansmann, G. Delsol, S.A. Pileri, and D.Y. Mason Expression of intracellular signaling molecules in classical and lymphocyte predominance Hodgkin disease Blood 103 2004 188 193
15. Z. Fan, Y. Natkunam, E. Bair, R. Tibshirani, and R.A. Warnke Characterization of variant patterns of nodular lymphocyte predominant Hodgkin lymphoma with immunohistological and clinical correlation Am J Surg Pathol 27 2003 1346 1356
16. S. Hartmann, D.A. Eichenauer, A. Plutschow, A. Mottok, and R. Bob The prognostic impact of variant histology in nodular lymphocyte predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG) Blood 122 2013 4246 4252
17. P.M. Mauch, L.A. Kalish, M. Kadin, C.N. Coleman, R. Osteen, and S. Hellman Patterns for presentation of Hodgkin disease. Implications for etiology and pathogenesis Cancer 71 1993 2062 2071
18. V.I. Pappa, A.J. Norton, R.K. Gupta, A.M. Wilson, A.Z. Rohatiner, and T.A. Lister Nodular type of lymphocyte-predominant Hodgkin's disease. A clinical study of 50 cases Ann Oncol 6 1995 559 565
19. S. Bodis, M.D. Kraus, and G. Pinkus et al. Clinical presentation and outcome in lymphocyte-predominant Hodgkin's disease J Clin Oncol 15 1997 3060 3066
20. L. Nogová, T. Reineke, and H.T. Eich et al. Extended field radiotherapy, combined modality treatment or involved field radiotherapy for patients with stage IA lymphocyte predominant Hodgkin's lymphoma: a retrospective analysis from the German Hodgkin Study Group (GHSG) Ann Oncol 16 2005 1683 1687
21. M. Miettinen, K.O. Franssila, and E. Saxén Hodgkin's disease, lymphocyte-predominance nodular. Increased risk of subsequent non-Hodgkin's lymphomas Cancer 51 1983 2293 2300
22. M.L. Hansmann, T. Zwingers, A. Böske, H. Löffler, and K. Lennert Clinical features of nodular paragranuloma (Hodgkin's disease, lymphocyte predominance type, nodular) J Cancer Res Clin Oncol 108 1984 321 330
23. P.J. Schlembach, R.B. Wilder, and D. Jones et al. Radiotherapy alone for lymphocyte-predominant Hodgkin's disease Cancer J 8 2002 377 383
24. A. Wirth, K. Yuen, and M. Barton et al. Long term outcome after radiotherapy alone for lymphocyte predominant Hodgkin's lymphoma: a retrospective multicenter study of the Australian Radiation Oncology Lymphoma Group Cancer 104 2005 1221 1229
25. R.C. Chen, M.S. Chin, and A.K. Ng et al. Early stage, lymphocyte predominant Hodgkin's lymphoma: patient outcomes form a large, single institution series with long follow up J Clin Oncol 28 2009 136 141
26. R.B. Wilder, P.J. Schlembcach, and D. Jones et al. European Organization for Research and Treatment of Cancer and Groupe d'Etude des Lymphomes de l'Adulte very favorable and favorable, lymphocyte-predominant Hodgkin disease Cancer 94 2002 1731 1738
27. P. Feugier, E. Labouyrie, and M. Djeridane et al. Comparison of initial characteristics and long term outcome of patients with lymphocyte-predominant Hodgkin lymphoma and classical Hodgkin lymphoma at clinical stages IA and IIA prospectively treated by brief anthracycline based chemotherapies plus extended high dose irradiation Blood 104 2004 2675 2681
28. K.G. Savage, B. Skinnider, M. Al Mansour, L.H. Sehn, R.D. Gascoyne, and J.M. Connors Treating limited stage nodular lymphocyte predominant hodgkin lymphoma similarly to classical Hodgkin lymphoma with ABVD may improve outcome Blood 118 2011 4585 4590
29. A. Shankar, G.W. Hall, S. Gorde-Grosjean, D. Hasenclever, and T. Leblanc Treatment outcome after low intensity chemotherapy [CVP] in children and adolescents with early stage nodular lymphocyte predominant Hodgkin's lymphoma - an Anglo-French collaborative report Eur J Cancer 48 2012 1700 1706
30. D. Eichenauer, M. Fuchs, A. Pluetschow, B. Klimmm, T. Halbsguth, and B. Boll Phase 2 study of rituximab in newly diagnosed stage I A nodular lymphocyte predominant Hodgkin lymphoma: a report from German Hodgkin Study Group Blood 118 2011 4363 4365
31. R. Advani, S.J. Horning, R. Hoppe, S. Daadi, J. Allen, and Y. Natkunam Front line therapy of nodular lymphocyte predomiant Hodgkin lymphoma with rituximab. The Stanford University experience ASH Annual Meeting 2011 (abstract 2686)
32. M.A. Fanale, C.M. Lai, McLaughlin, J.E. Romaguera, and L. Fayad Outcome of nodular lymphocyte predominant Hodgkin's lymphoma (NLPHL) patients treated with R-CHOP ASH Annual Meeting 2010 (abstract 2812)
33. H. Schulz, U. Rehwald, F. Morschhauser, T. Elter, C. Driessen, and T. Rudiger Rituximab in relapsed lymphocyte predominant Hodgkin's lymphoma: long-term results of a phase 2 trial by the German Hodgkin Study Group (GHSG) Blood 111 2008 109 111
34. B.C. Ekstrand, J.B. Lucas, S.M. Horowitz, Z. Fan, and S. Breslin Rituximab in lymphocyte predominant Hodgkin disease: results of a phase 2 trial Blood 101 2003 4285 4289
35. + Hodgkin lymphoma with the monoclonal antibody rituximab is effective and well tolerated: results of a phase II trial of the German Hodgkin Lymphoma Study Group Blood 101 2003 420 424
36. M. Karuturi, C. Hosing, and M. Fanale et al. High dose chemotherapy and autologous stem cell transplantation for nodular lymphocyte predominant Hodgkin lymphoma Biol Blood Marrow Transplant 19 2013 991 994
37. C. Jackson, B. Sirohi, D. Cunnningham, A. Horwich, K. Thomas, and A. Wotherspoon Lymphocyte-predominant Hodgkin lymphoma-clinical features and treatment outcomes from a 30-year experience Ann Oncol 21 2010 2061 2068
38. J.Z. Huang, D.D. Weisenburger, J.M. Vose, T.C. Greiner, and P. Aoun Diffuse large B-cell lymphoma arising in nodular lymphocyte predominant Hodgkin lymphoma: a report of 21 cases from the Nebraska Lymphoma Study Group Leuk Lymphoma 45 2004 1551 1557
39. I. Biasoli, A. Stamatoullas, and V. Meignin et al. Nodular, lymphocyte-predominant Hodgkin lymphoma: a long-term study and analysis of transformation to diffuse large B-cell lymphoma in a cohort of 164 patients from the Adult Lymphoma Study Group Cancer 116 2010 631 639
40. S.J. Sirop, T.M. Habermann, W.R. Macon, K.M. Ristow, S.M. Ansell, and J.P. Colgan Diffuse large B cell transformation in nodular lymphocyte predominant Hodgkin lymphoma: incidence, risk factors and outcomes after a forty year experience from a single institution ASH Annual Meeting 2012 (abstract 1525)
41. K.H. Xing, J.M. Connors, M.A. Mansour, and R.D. Gascoyne The outcome of advanced stage nodular lymphocyte predominant Hodgkin's lymphoma (NLPHL) compared to classical Hodgkin Lymphoma (CHL): a matched pair analysis ASH Annual Meeting 2012 (abstract 1531)